Concepedia
Statistics
Publications
16
Citations
767
H-Index
12
Active since
1998
Affiliations
Karolinska Institutet(Current)
Catholic University of Health and Allied Sciences
Karolinska University Hospital
Muhimbili University of Health and Allied Sciences
University of Botswana
Mary Jande is an author at Karolinska Institutet specializing in pharmacology, pharmacy, and medicine.
Publications per year
1998–2017
4β-Hydroxycholesterol is a new endogenous CYP3A marker: relationship to CYP3A5 genotype, quinine 3-hydroxylation and sex in Koreans, Swedes and Tanzanians
Ulf Diczfalusy, Jun Miura, Hyung‐Keun Roh et al. · Pharmacogenetics and Genomics · 2008 · 150 citations
Medicine, Biochemistry, Pharmacology +15
Bantu Tanzanians have a decreased capacity to metabolize omeprazole and mephenytoin in relation to their CYP2C19 genotype*
Karin Herrlin, Amos Massele, Mary Jande et al. · Clinical Pharmacology & Therapeutics · 1998 · 94 citations
Medicine, Pharmacokinetics, Pharmacology +13
CYP3A5 genotype has significant effect on quinine 3-hydroxylation in Tanzanians, who have lower total CYP3A activity than a Swedish population
Rajaa A. Mirghani, Jane Sayi, Eleni Aklillu et al. · Pharmacogenetics and Genomics · 2006 · 86 citations
Medicine, Pharmacokinetics, Pharmacology +16
CYP3A5 Genotype has an Impact on the Metabolism of the HIV Protease Inhibitor Saquinavir
Filip Josephson, Annika Allqvist, Mohamed Janabi et al. · Clinical Pharmacology & Therapeutics · 2007 · 64 citations
Medicine, Pharmacokinetics, Pharmacology +15
Identification and phenotype characterization of two haplotypes causing different enzymatic capacity in fetal livers
Cristina Rodríguez‐Antona, Mary Jande, Anders Rane et al. · Clinical Pharmacology & Therapeutics · 2005 · 60 citations
Life Sciences, Biochemistry, Genetics +16
1–5 of 16